Below you can register for ELPA Symposium 2019, which will be held as part of the official program at the International Liver Congress 2019.
ELPA Symposium in 2019 will be dedicated to presentations about NAFLD and NASH today from the medical and patient perspective. Prevalence of NAFLD and NASH is increasing, cirrhosis and liver failure associated with NAFLD and NASH is increasingly recognized as indications for liver transplant, and patients should be monitored carefully for avoiding co-morbid factors linked because their risk of cardiovacular serious events. Today we do not have drug medications and only have diagnosis, medical advice and sometimes derivation to the hospital. The focus should be on the work on the need for a great multidisciplinary evaluation and follow up, requiring the creation, in some centres already existing, of a very committed multidisciplinary team.
The Symposium will be held on the 11th of April from 10:30 - 12:50 in the hall Strauss 1-2.
Chairs of the meeting:
Dr. Teresa Casanovas, Leader of ELPA Scientific Committee,
prof. dr. Helena Cortez-Pinto, EASL EU Policy Councillor
Welcome and introduction
Diagnosis of NAFLD/NASH
Dr Emmanuel Tsochatzis
NAFLD/NASH and importance of right nutrition
Dr Shira Zelber-Sagi
Clear information is the key for patients
Dr Antoni Amor
Role of Transient Elastography (Fibroscan)
Dr Laurent Castera
How to find the patients – research project LiverScreen
Núria Fabrellas Padrés
NAFLD/NASH Policy Review from patient perspective
Prof. Jeffrey Lazarus
Patients views and problems in NAFLD/NASH
Group Discussion and Closing remarks